Figure 1.
Mean plasma concentrations of mirogabalin in subjects with varying degrees of renal impairment after a single oral 5‐mg dose. ESRD, end‐stage renal disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.